Advertisement

Native and Prosthetic Valve Endocarditis

  • Amina Khalil
  • Jonathan AndersonEmail author
Chapter

Abstract

Infective endocarditis (IE) is an endovascular microbial infection of the endocardium that includes the great intrathoracic vessels and intracardiac devices exposed to the blood interface but with a higher predilection for the cardiac valves. The factors contributing to the development of IE have changed over the past 50 years. These factors include a decreasing incidence of rheumatic heart disease, an increase in median age, heart valve surgery, nosocomial infections and intravenous drug misuse. The epidemiology, diagnosis, treatment and surgical techniques are discussed in this chapter.

Keywords

Epidemiology Prosthetic valve endocarditis Nosocomial Antibiotics Abscess Biofilm Embolus 

References

  1. 1.
    Horstkotte D, Follath F, Gutschil E, Lengyel M, Oto A, Pavie A, et al. Guidelines on prevention diagnosis and treatment of infective endocarditis executive summary. The task force on infective endocarditis of the European Society of Cardiology. Eur Heart J. 2004;25:167–76.CrossRefGoogle Scholar
  2. 2.
    Prendergast BD. The changing face of infective endocarditis. Heart. 2006;92:879–85.PubMedCrossRefGoogle Scholar
  3. 3.
    Grant RT, Wood JE, Jones TD. Heart valve irregularities in relation to the sub-acute bacterial endocarditis. Heart. 1928;14:247–61.Google Scholar
  4. 4.
    Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clinic Proc. 2010;85:422–6.CrossRefGoogle Scholar
  5. 5.
    Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 2004;923:1–122.Google Scholar
  6. 6.
    Michael PL, Acar J. Native cardiac disease predisposing to endocarditis. Eur Heart J. 1995;16:2–6.CrossRefGoogle Scholar
  7. 7.
    Watanakunakorn C, Burkert T. Infective endocarditis as t a large community teaching hospital, 1980 – 1990: a review of 210 cases. Medicine. 1993;72:90–102.PubMedCrossRefGoogle Scholar
  8. 8.
    Benito N, Miro JM, de Lazzari E, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009;150:586–94.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Berlin JA, Abrutyn E, Strom BL, et al. Incidence od infective endocarditis in Delaware Valley, 1988–1990. Am J Cardiol. 1995;76:933.PubMedCrossRefGoogle Scholar
  10. 10.
    Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore). 1995;74:324–39.CrossRefGoogle Scholar
  11. 11.
    Slipczuk L, Codolosa JN, Davial CD, Romero-Corral A, Yun J, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2014;9:e111564.CrossRefGoogle Scholar
  12. 12.
    Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis. 1999;5:9–17.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide inpatient sample database. Arch Intern Med. 2005;165:1756–61.PubMedCrossRefGoogle Scholar
  14. 14.
    Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin N Am. 2005;23:73–98.CrossRefGoogle Scholar
  15. 15.
    Munita JM, Arias CA, Murray BE. Enterococcal endocarditis: can we win the war? Curr Infect Dis Rep. 2012;14:339–49.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81.PubMedCrossRefGoogle Scholar
  17. 17.
    Bouza E, Menasalvas A, Munoz P, Vasallo FJ. Infective endocarditis - a prospective study at the end of the twentieth century. Medicine. 2001;80:298–307.PubMedCrossRefGoogle Scholar
  18. 18.
    Sidhu P, O’Kane H, Ali N, et al. Mechanical or bioprosthetic valves in the elderly: a 20-year comparison. Ann Thorac Surg. 2001;71:S257–60.PubMedCrossRefGoogle Scholar
  19. 19.
    Varstela E. Personal follow-up of 100 aortic valve replacement patients for 1081 patient years. Ann Chir Gynaecol. 1998;87:205–12.PubMedGoogle Scholar
  20. 20.
    Castillo JC, Anguita MP, Torres F, et al. Long-term prognosis of early and late prosthetic valve endocarditis. Am J Cardiol. 2004;93:1185–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Rivas P, Alonso J, Moya J, et al. The impact of hospital-acquired infections on the microbial etiology and prognosis of late-onset prosthetic valve endocarditis. Chest. 2005;128:764–71.PubMedCrossRefGoogle Scholar
  22. 22.
    Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J. 1995;16:84–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Moreillon P, Que YE. Infective endocarditis. Lancet. 2004;363:139–49.PubMedCrossRefGoogle Scholar
  24. 24.
    Pierrotti LC, Baddour LM. Fungal endocarditis, 1995–2000. Chest. 2002;122:302–10.PubMedCrossRefGoogle Scholar
  25. 25.
    Giamarellou H. Nosocomial cardiac infections. J Hosp Infect. 2002;50:91–105.PubMedCrossRefGoogle Scholar
  26. 26.
    Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis - prospective cohort study. Arch Intern Med. 2009;169:463–73.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Thiene G, Basso C. Pathology and pathogenesis of infective endocarditis I native heart valves. Cardiovac Pathol. 2006;15:256–63.CrossRefGoogle Scholar
  28. 28.
    Baddour LM. Virulence factors among gram-positive bacteria in experimental endocarditis. Infect Immun. 1994;62:2143–8.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Fowler VG Jr, McIntyre LM, Yeaman MR, Peterson GE, Barth RL, et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis. 2000;182:1251–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;369:785.PubMedCrossRefGoogle Scholar
  31. 31.
    Mansur AJ, Grinberg M, da Luz PL, Bellotti G. The complications of infective endocarditis. A reappraisal in the 1980s. Arch Intern Med. 1992;152:2428.PubMedCrossRefGoogle Scholar
  32. 32.
    Oakley C. The mitral kissing vegetation. Eur Heart J. 2002;23:11–2.PubMedCrossRefGoogle Scholar
  33. 33.
    John RJM, Treaure T, Sturridge MF, Swanton RM. Aortic root complications of infective endocarditis: influence on surgical outcomes. Eur Heart J. 1991;12:241–8.PubMedCrossRefGoogle Scholar
  34. 34.
    David TE, Komeda M, Brofman PR. Surgical treatment of aortic root abscess. Circulation. 1989;80:1269–74.CrossRefGoogle Scholar
  35. 35.
    Rohmann S, Erbel R, Mohr-Kahaly S, Meyer J. Use of transesophageal echocardiography in the diagnosis of abscess in infective endocarditis. Eur Heart J. 1995;16:S54–62.CrossRefGoogle Scholar
  36. 36.
    Blumberg EA, Karalis DA, Chandrasekaran K, et al. Endocarditis-associated paravalvular abscesses—do clinical parameters predict the presence of abscess? Chest. 1995;107:898–903.PubMedCrossRefGoogle Scholar
  37. 37.
    Spirito P, Bellone P, Bertocchi S, Autore C, et al. Infective endocarditis in patients with hypertrophic cardiomyopathy: prevalence, incidence and indications of antibiotic prophylaxis. Circulation. 1999;99:2132–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Misfeld M, Girrbach F, Etz CD, Binner C, Aspern KV, et al. Surgery for infective endocarditis complicated by cerebral embolism: a consecutive series of 375 patients. J Thorac Cardiovasc Surg. 2014;147:1837–46.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Corral I, Martin-Davilla P, Fortun J, Navas E, Centella T, Moya JL, et al. Trends in neurological complications of endocarditis. J Neurol. 2007;254:1253–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354–61.PubMedCrossRefGoogle Scholar
  41. 41.
    Folwer VG Jr, Miro JM, Hoen B, et al. Staphylococcus Aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:1354–61.Google Scholar
  42. 42.
    Cabell CH, Abrutyn E. Progress towards a global understanding of infective endocarditis. Lessons from the international collaboration of infective endocarditis. Cardiol Clin. 2003;21:147–58.PubMedCrossRefGoogle Scholar
  43. 43.
    Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, et al. Non-HACEK gram-negative Bacillus endocarditis. Ann Intern Med. 2007;147:829–35.PubMedCrossRefGoogle Scholar
  44. 44.
    Hauser M, Hess J, et al. Treatment of Candida Albicans endocarditis: case report and a review. Infection. 2003;31:125–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Durack DT, Lukes AS, Bright DK, Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Hoen B, Beguinot I, Rabaid C, et al. The Duke criteria for diagnosing infective endocarditis are specific: analysis of 100 patients with acute fever or fever of unknown origin. Clin Infect Dis. 1996;23:298–302.PubMedCrossRefGoogle Scholar
  47. 47.
    Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J. Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol. 1996;77:403–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Gould FK, Denning DW, Elliott TS, et al. Guidelines for diagnosis and treatment of endocarditis in adults: a working party of British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2012;67:269–89.PubMedCrossRefGoogle Scholar
  49. 49.
    Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart. 2003;89:258–62.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Lepidi H, Coulibaly B, Casalta JP, Raoult D. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. J Infect Dis. 2006;193:1711–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Evangelista A, Gonza ́lez-Alujas MT. Echocardiography in infective endocarditis. Heart. 2004;90:614–7.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Shapiro SM, Young E, De Guzman S, et al. Transesophageal echocardiography in diagnosis of infective endocarditis. Chest. 1994;105:377–82.PubMedCrossRefGoogle Scholar
  53. 53.
    Erbel R, Rohmann S, Drexler M, et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J. 1988;9:43–53.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Erbel R. The new strategy in infective endocarditis: early surgery based on early diagnosis are we too late when early surgery is best? Circulation. 2015;131:121–3.PubMedCrossRefGoogle Scholar
  55. 55.
    Daniel WG, Mu ̈gge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324:795–800.PubMedCrossRefGoogle Scholar
  56. 56.
    Karalis DG, Bansal RC, Hauck AJ, et al. Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Circulation. 1992;86:353–62.PubMedCrossRefGoogle Scholar
  57. 57.
    Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management based approach. Arch Intern Med. 2009;169:1290–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:394–434.CrossRefGoogle Scholar
  59. 59.
    Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC): endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemo- therapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.PubMedCrossRefGoogle Scholar
  60. 60.
    Miro JM, Anguera I, Cabell CH, Chen AY, et al. Staphylococcus Aureus native valve infective endocarditis: report on 566 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis. 2005;41:507–14.PubMedCrossRefGoogle Scholar
  61. 61.
    Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, Blackstone E. Aortic valve replacement for active infectious endocarditis in 108 patients. A comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg. 1992;103:130–9.PubMedGoogle Scholar
  62. 62.
    Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH. Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation. 1994;90:S198–204.Google Scholar
  63. 63.
    Yankah AC, Klose H, Petzina R, Musci M, Siniawski H, Hetzer R. Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience. Eur J Cardiothorac Surg. 2002;21:260–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Kang DH, Kim YJ, Kim SH, et al. Early surgery vs conventional treatment for infective endocarditis. N Engl J Med. 2012;336:2466–73.CrossRefGoogle Scholar
  65. 65.
    Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Magngoni E, Pericas JM, Fernandez-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A, for the ICE Investigators. Association between surgical indications, operative risk, and clinical out- come in infective endocarditis: a prospective study from the international collaboration on endocarditis. Circulation. 2015;131:131–40.PubMedCrossRefGoogle Scholar
  66. 66.
    Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121:1141–52.PubMedCrossRefGoogle Scholar
  67. 67.
    Moon MR, Dc M, Moore KC, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg. 2001;71:1164–71.CrossRefGoogle Scholar
  68. 68.
    Lytle BW, Priest BP, Taylor PC, et al. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1996;111:198–210.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Evans CF, Gammie JS. Surgical management of mitral valve infective endocarditis. Semin Thorac Cardiovasc Surg. 2011;23:232–40.PubMedCrossRefGoogle Scholar
  70. 70.
    Zegdi R, Khabbaz Z, Flecher E, et al. Management of commissural lesions in native mitral valve endocarditis: long-term results of valve repair and partial homograft replacement. J Heart Valve Dis. 2006;15:356–9.PubMedGoogle Scholar
  71. 71.
    Ruttmann E, Legit C, Poelzl G, et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg. 2005;130:765–71.PubMedCrossRefGoogle Scholar
  72. 72.
    Sternik L, Zehr KJ, Orszulak TA, et al. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis. 2002;11:91–7.PubMedGoogle Scholar
  73. 73.
    Feringa HHH, Shaw LJ, Poldermans D, et al. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg. 2007;83:564–71.PubMedCrossRefGoogle Scholar
  74. 74.
    D’Udekem Y, David TE, Feindel CM, et al. Long term results of operation for paravalvular abscess. Ann Thorac Surg. 1996;62:48–53.PubMedCrossRefGoogle Scholar
  75. 75.
    Jault F, Gandjbakhch I, Chastre JC, et al. Prosthetic valve endocarditis with ring abscesses: surgical management and long-term results. J Thorac Cardiovasc Surg. 1993;105:1106–13.PubMedGoogle Scholar
  76. 76.
    David TE, Kuo J, Armstrong S. Aortic and mitral valve replacement with reconstruction of intervalvular fibrous body. J Thorac Cardiovasc Surg. 1997;114:766–71.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    David TE, Gavra G, Feindel CM, Regesta T, et al. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg. 2007;133:144–9.CrossRefGoogle Scholar
  78. 78.
    Siniawski H, Grauhan O, Hofmann M, et al. Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment. Eur J Cardiothorac Surg. 2005;27:434–40.PubMedCrossRefGoogle Scholar
  79. 79.
    Grinda JM, Mainardi JL, D’Attellis N, et al. Cryopreserved aortic viable homograft for active aortic endocarditis. Ann Thorac Surg. 2005;79:767–71.PubMedCrossRefGoogle Scholar
  80. 80.
    Lytle BW, Sabik JF, Blackstone EH, Svensson LG, Pettersson GB, Cosgrove DM. Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. Ann Thorac Surg. 2002;74:S1754–9.CrossRefGoogle Scholar
  81. 81.
    David TE, Regesta T, Gavra G, et al. Surgical treatment of paravalvular abscess: long-term results. Eur J Cardiothorac Surg. 2007;31:43–8.PubMedCrossRefGoogle Scholar
  82. 82.
    David TE, Feindel CM, Armstrong S. Reconstruction of mitral annulus. A ten year experience. J Thorac Cardiovasc Surg. 1995;110:1323–32.PubMedCrossRefGoogle Scholar
  83. 83.
    Obaida JF, Raisky O, Sebbag L, et al. Monobloc aorto-mitral homograft as a treatment of complex cases of endocarditis. J Thorac Cardiovasc Surg. 2001;121:584–6.CrossRefGoogle Scholar
  84. 84.
    Carozza A, Renzulli A, De Feo M, Ismeno G, et al. Tricuspid repair for infective endocarditis: clinical and echocardiographic results. Tex Heart Inst J. 2001;28:96–101.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Couetil JP, Argyriadis PG, Shafy A, et al. Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis. Ann Thorac Surg. 2002;73:1808–12.PubMedCrossRefGoogle Scholar
  86. 86.
    Yee ES, Ullyot DJ. Reparative approach for right-sided endocarditis. Operative considerations and results of valvuloplasty. J Thorac Cardiovasc Surg. 1988;96:133–40.PubMedGoogle Scholar
  87. 87.
    De Vega N. Selective, adjustable and permanent annuloplasty. An original technique for the treatment of tricuspid insufficiency. Rev Esp Cardiol. 1972;25:555–60.PubMedGoogle Scholar
  88. 88.
    Kay JH, Maselli-Campagna G, Tsuji HK. Surgical treatment of tricuspid insufficiency. Ann Surg. 1965;162:53–8.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Zegdi R, Debieche M, Latremouille C, et al. Long-term results of mitral valve repair in active endocarditis. Circulation. 2005;111:2532–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Byrne JG, Rezai K, Sanchez JA, Bernstein RA, et al. Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg. 2011;91:2012–9.PubMedCrossRefGoogle Scholar
  91. 91.
    Arbulu A, Asfaw I. Tricuspid valvulectomy without prosthetic replacement. Ten years of clinical experience. J Thorac Cardiovasc Surg. 1981;82:684–91.PubMedGoogle Scholar
  92. 92.
    Lopez J, Revilla A, Vilacosta I, et al. Multiple-valve infective endocarditis: clinical, microbiologic, echocardiographic, and prognostic profile. Medicine. 2011;90:231–6.PubMedCrossRefGoogle Scholar
  93. 93.
    Gillinov AM, Diaz R, Blackstone EH, et al. Double valve endocarditis. Ann Thorac Surg. 2001;71:1874–9.PubMedCrossRefGoogle Scholar
  94. 94.
    Mihaljevic T, Byrne JG, Cohn LH, Aranki SF. Long-term results of multivalve surgery for infective multivalve endocarditis. Eur J Cardiothorac Surg. 2001;20:842–6.PubMedCrossRefGoogle Scholar
  95. 95.
    Cooper HA, Thompson EC, Laureno R, et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation. 2009;120:585–91.PubMedCrossRefGoogle Scholar
  96. 96.
    Halder SM, O’Gara PT. Infective endocarditis: diagnosis and management. Nat Clin Pract Cardiovasc Med. 2006;3(6):310–7.Google Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Cardiothoracic SurgeryHammersmith HospitalLondonUK

Personalised recommendations